BRI has joined the initial research initiative of the new Allen Institute for Immunology, a new division of the Institute dedicated to studying the human immune system.
The Allen Institute for Immunology’s goal is to improve human immune health and lay the groundwork for better ways to diagnose, treat and prevent immune-related diseases.
The Institute will focus on three autoimmune disorders, rheumatoid arthritis, ulcerative colitis and Crohn’s disease as well as two cancers, multiple myeloma and melanoma.
BRI’s role, led by Jane Buckner, MD, will be to provide a baseline of knowledge about the healthy immune system, which will serve as a foundation for the institute’s disease research programs.
BRI joins Fred Hutchinson Cancer Research Center; the University of California San Diego with the University of Colorado Anschutz Medical Campus; and the University of Pennsylvania in partnering with the Allen Institute for Immunology to accelerate progress in the field of immunology research.